Merck aiming to help biopharmas make CHO cells resistant to MVM
Germany's Merck says gene editing can make CHO cells resistant to a tiny mouse virus that continues to be a problem for even animal component-free production processes.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs